-
FDA Grants Jemperli Breakthrough Therapy Designation in dMMR/MSI-H Rectal Cancer
21 Dec 2024 23:42 GMT
… therapies for gynecologic, colorectal and lung cancers. This proves an important task … is indicated in combination with carboplatin and paclitaxel, followed by Jemperli …
-
HUTCHMED Announces Breakthrough Therapy Designation in China for ORPATHYS® and TAGRISSO® Combination in Certain Lung Cancer Patients After Disease Progression on EGFR Inhibitor Therapy
12 Dec 2024 04:00 GMT
… ‑positive non‑small cell lung cancer (“NSCLC”) with MET … (pemetrexed plus cisplatin or carboplatin), the standard‑of‑care … of EGFR TKI-resistant lung cancer. Journal of Hematology … cell lung cancer – A systematic review and meta-analysis. Lung Cancer. 2018 …
-
Lantern Pharma starts dosing in Taiwan in non-smoker lung cancer trial
09 Dec 2024 20:07 GMT
… patients with non-small cell lung cancer (NSCLC).
The first … than half of all new lung cancer cases (53%) turned … proportion of never-smoker lung cancer patients in Taiwan makes … combination with two chemotherapies, carboplatin and pemetrexed.
In the …
-
Incyte Announces Positive Results from Phase 3 Trial Evaluating Retifanlimab (Zynyz®) in Combination with Platinum-Based Chemotherapy in Patients with Non-Small Cell Lung Cancer
07 Dec 2024 12:42 GMT
… metastatic non-small cell lung cancer (NSCLC) not … Lung Cancer
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer … , accounting for approximately 85% of all lung cancer … with pemetrexed and carboplatin/cisplatin for …
-
AstraZeneca's Imfinzi receives US FDA approval to treat patients with limited─stage small cell lung cancer
06 Dec 2024 04:06 GMT
… extensive-stage small cell lung cancer, underscoring our commitment … (etoposide and either carboplatin or cisplatin) for … portfolio includes leading lung cancer medicines and the … improvements for people with lung cancer, including and beyond treatment …
-
IMFINZI® (durvalumab) approved in the US as first and only immunotherapy regimen for patients with limited-stage small cell lung cancer
05 Dec 2024 12:23 GMT
… Notes
Small cell lung cancer
Lung cancer is the leading … combination with chemotherapy (carboplatin and paclitaxel) … for people with lung cancer, including and beyond … lung-cancer-101/types-of-lung-cancer.
American Cancer Society. Small cell lung cancer …
-
FDA Grants Breakthrough Therapy Designation to Sacituzumab Tirumotecan (sac-TMT) for the Treatment of Certain Patients With Previously Treated Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer With EGFR Mutations
03 Dec 2024 11:55 GMT
… non-small cell lung cancer (NSCLC) with … chemotherapy (pemetrexed and carboplatin) in certain patients … and Taiwan).
About lung cancer
Lung cancer is the leading cause … lung cancer globally. Non-small cell lung cancer is the most common type of lung cancer …
-
Analysis of the Effects of Bevacizumab Combined with Chemoradiotherapy on VEGF, bFGF, and Let-7 Levels in Non-Small Cell Lung Cancer and the Factors Influencing Therapeutic Efficacy: A Retrospective Cohort Study
02 Dec 2024 18:59 GMT
… subtypes, non-small cell lung cancer (NSCLC) predominates, … lung cancer and induce cell cycle arrest of lung cancer … JR. Non-small cell lung cancer: epidemiology, screening, diagnosis, … bevacizumab, paclitaxel and carboplatin for first-line treatment …
-
Telford man living with lung cancer issues plea to help save lives
29 Nov 2024 11:59 GMT
… support Cancer Research UK during Lung Cancer Awareness Month.
Campaign to help … revealed critical insights into how lung cancer evolves and spreads and developing … two types of chemotherapy including carboplatin and etoposide phosphate, which Cancer …
-
Afatinib Combined with Bevacizumab in the Treatment of Patients with Non-Small Cell Lung Cancer Harboring EGFR G719X, S768I or L861Q/P Mutations
25 Nov 2024 11:17 GMT
… oncogenic drivers in lung cancers to select targeted drugs … et al. Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma. … with non-small cell lung cancer. Lung Cancer. 2015;87(2): … cell lung cancer: new evidence and treatment. Transl Lung Cancer Res. …